Grifols SA – Strategy, SWOT and Corporate Finance Report

Grifols SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Grifols SA (Grifols) focuses on improving the health and well-being of people around the world. It conducts research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in the production of plasma-derived medicines and has plasma donation centers across the US. Grifols provides a wide range of transfusion medicine, hemostasis and immunoassay solutions for blood banks, clinical laboratories and transfusion centers. It produces plasma derived protein therapies for patients suffering with rare, genetic diseases and life-threatening infections. The company offers its products to hospitals, pharmacies and healthcare professionals. Grifols is headquartered in Sant Cugat del Valles, Barcelona, Spain.

Scope

Detailed information on Grifols SA required for business and competitor intelligence needs

A study of the major internal and external factors affecting Grifols SA in the form of a SWOT analysis

An in-depth view of the business model of Grifols SA including a breakdown and examination of key business segments

News about Grifols SA, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Grifols SA and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Grifols SA as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Grifols SAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

AB-Biotics SA

Omnicell Inc

HemaCare Corp

CSL Ltd

Oryzon Genomics SA

Abeona Therapeutics Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Grifols SA - Key Facts

Grifols SA - Key Employees

Grifols SA - Key Employee Biographies

Grifols SA - Major Products and Services

Grifols SA - History

Grifols SA - Company Statement

Grifols SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 Company Analysis

Company Overview

Grifols SA - Business Description

Business Segment: Bio Supplies

Overview

Performance

Business Segment: Bioscience

Overview

Performance

Business Segment: Diagnostic

Overview

Performance

Business Segment: Hospital

Overview

Performance

Business Segment: Others

Overview

Performance

Geographical Segment: European Union

Performance

Geographical Segment: Rest of World

Performance

Geographical Segment: Spain

Performance

Geographical Segment: USA and Canada

Performance

R&D Overview

Grifols SA - Corporate Strategy

Grifols SA - SWOT Analysis

SWOT Analysis - Overview

Grifols SA - Strengths

Grifols SA - Weaknesses

Grifols SA - Opportunities

Grifols SA - Threats

Grifols SA - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences, Power Financial Deals and Alliances

Grifols SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Grifols SA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Grifols SA, Recent Deals Summary

Section 5 Company’s Recent Developments

Apr 30, 2019: Grifols Announces PharmacyKeeper Bidirectional Integration with Epic

Apr 29, 2019: Grifols announces the opening of its new Plasma Donor Center in Hinesville, Georgia

Apr 15, 2019: Grifols donations of blood clotting factor helping people with hemophilia globally

Apr 11, 2019: Healthcare Providers Worldwide Adopt Cisco ACI as their Prescription for IT Excellence

Mar 29, 2019: Grifols presents new data to support the effectiveness of its clinical trial to treat Alzheimer's

Mar 23, 2019: Grifols announces the opening of its new plasma donor center in Russellville, AR

Feb 28, 2019: Grifols reports EUR 4,487 million in revenues, with

9.2% operating growth and EUR 597 million in net profit

Oct 29, 2018: Grifols affirms commitment to patients during Alpha-1 Awareness Month

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Grifols SA, Key Facts

Grifols SA, Key Employees

Grifols SA, Key Employee Biographies

Grifols SA, Major Products and Services

Grifols SA, History

Grifols SA, Other Locations

Grifols SA, Subsidiaries

Grifols SA, Key Competitors

Grifols SA, Ratios based on current share price

Grifols SA, Annual Ratios

Grifols SA, Annual Ratios (Cont…1)

Grifols SA, Annual Ratios (Cont…2)

Grifols SA, Interim Ratios

Grifols SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Grifols SA, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Grifols SA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Grifols SA, Performance Chart (2014 – 2018)

Grifols SA, Ratio Charts

Grifols SA, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Grifols SA, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports